
Oorja Bio
Oorja Bio’s goal is to develop groundbreaking therapies for cardiopulmonary and fibrotic disorders that target the underlying pathophysiology of disease.
$30M Series A ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredSep 29, 2023 (3 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $30M | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
CC
Connie Coulomb Chief Business Officer & Foundersource: oorjabio.comJP
Janethe Pena Chief Medical Officer & Foundersource: oorjabio.comSK
Sujay Kango Chief Executive Officer & Foundersource: oorjabio.com
Companies like Oorja Bio
MMirador Therapeutics$250M Series B+ · Jan 2026
AAlzheon$100M Series B+ · Apr 2022
LLatus Bio$97M Series A · May 2026
CCelea Therapeutics$180M Series A · Jul 2026
AAstrocyte Pharmaceuticals$9.5M Series B+ · Sep 2026
CClaris Bio$118M Series B+ · Jul 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/oorja-bio (get a free API key).